Duloxetine (Cymbalta) for treatment of major depressive disorder

Carla Cobb, Renee Crichlow

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations


Duloxetine (Cymbalta) is a serotonin and norepinephrine reuptake inhibitor in the same class as venlafaxine (Effexor). It is approved by the U.S. Food and Drug Administration (FDA) for use in the treatment of major depressive disorder and of diabetic peripheral neuropathic pain. In Europe it is marketed for the treatment of stress urinary incontinence; it is not approved for that indication in the United States.

Original languageEnglish (US)
Pages (from-to)1099-1102
Number of pages4
JournalAmerican family physician
Issue number6
StatePublished - Sep 15 2005


Dive into the research topics of 'Duloxetine (Cymbalta) for treatment of major depressive disorder'. Together they form a unique fingerprint.

Cite this